MODR Z, DVORACEK K, JANKU I, Krebs V
Infection. 1982; 10 Suppl 3:S184-90.
PMID: 7152688
DOI: 10.1007/BF01640668.
Gundert-Remy U, Weber E
Eur J Clin Pharmacol. 1982; 22(5):435-9.
PMID: 7117356
DOI: 10.1007/BF00542549.
Brogden R, Heel R, Speight T, Avery G
Drugs. 1980; 20(5):325-52.
PMID: 7002527
DOI: 10.2165/00003495-198020050-00001.
Hoogkamp-Korstanje J, Westerdaal N
Infection. 1982; 10 Suppl 3:S257-61.
PMID: 6818158
DOI: 10.1007/BF01640684.
Aisa M, Omenaca M, Bergua C
Infection. 1982; 10 Suppl 3:S244-8.
PMID: 6818157
DOI: 10.1007/BF01640682.
Azlocillin, a ureido penicillin active against Pseudomonas aeruginosa: interpretive zone standards and quality control parameters for tests with 75-mu g disks.
Barry A, Jones R, Thornsberry C, Gavan T
J Clin Microbiol. 1982; 16(1):135-40.
PMID: 6809788
PMC: 272309.
DOI: 10.1128/jcm.16.1.135-140.1982.
In vitro comparison of N-formimidoyl thienamycin (MK0787) and Azlocillin with three aminoglycosides and ticarcillin against Pseudomonas aeruginosa.
Matzkowitz A, Baltch A, Smith R, Sutphen N, Hammer M, CONROY J
Antimicrob Agents Chemother. 1982; 21(4):685-7.
PMID: 6805426
PMC: 181971.
DOI: 10.1128/AAC.21.4.685.
Statistical comparison of the antibacterial activities of broad-spectrum penicillins against gram-negative bacilli.
Fass R
Antimicrob Agents Chemother. 1983; 24(2):156-62.
PMID: 6638985
PMC: 185130.
DOI: 10.1128/AAC.24.2.156.
Augmentation of the in vitro activity of azlocillin against Bacteroides fragilis by clavulanic acid.
Bansal M, Chuah S, Thadepalli H
Antimicrob Agents Chemother. 1984; 26(4):606-7.
PMID: 6517552
PMC: 179977.
DOI: 10.1128/AAC.26.4.606.
Comparative activity of mezlocillin, penicillin, ampicillin, carbenicillin, and ticarcillin against gram-positive bacteria and Haemophilus influenzae.
Sanders C
Antimicrob Agents Chemother. 1981; 20(6):843-6.
PMID: 6459766
PMC: 181811.
DOI: 10.1128/AAC.20.6.843.
[Concentrations of mezlocillin in cerebrospinal fluid in vira meningitis (author's transl)].
Hoffmann H, Forster D, Schoen I
Infection. 1980; 8(4):162-4.
PMID: 6457803
DOI: 10.1007/BF01639124.
Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function.
Frimodt-Moller N, Maigaard S, Toothaker R, Bundtzen R, Brodey M, Craig W
Antimicrob Agents Chemother. 1980; 17(4):599-607.
PMID: 6446877
PMC: 283838.
DOI: 10.1128/AAC.17.4.599.
Azlocillin compared with carbenicillin in the treatment of bronchopulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis.
Penketh A, Hodson M, Gaya H, Batten J
Thorax. 1984; 39(4):299-304.
PMID: 6426075
PMC: 459787.
DOI: 10.1136/thx.39.4.299.
In vitro and in vivo studies of three antibiotic combinations against gram-negative bacteria and Staphylococcus aureus.
Zinner S, Klastersky J, Gaya H, Bernard C, Ryff J
Antimicrob Agents Chemother. 1981; 20(4):463-9.
PMID: 6282192
PMC: 181724.
DOI: 10.1128/AAC.20.4.463.
In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.
Baker C, Thornsberry C, Jones R
Antimicrob Agents Chemother. 1980; 17(4):757-61.
PMID: 6249195
PMC: 283867.
DOI: 10.1128/AAC.17.4.757.
[Pharmacokinetics and dosage of mezlocillin administered by intravenous infusion].
MODR Z, DVORACEK K, JANKU I, Krebs V
Infection. 1982; 10 Suppl 3:S191-5.
PMID: 6218111
DOI: 10.1007/BF01640669.
An assessment of the intramuscular and intravenous administration of mezlocillin in urinary tract infections.
Del Rio G, Dalet F
Infection. 1982; 10 Suppl 3:S176-81.
PMID: 6218109
DOI: 10.1007/BF01640666.
Comparative penetration of azlocillin and mezlocillin into cerebrospinal fluid of normal rabbits and rabbits with experimentally induced Pseudomonas aeruginosa meningitis.
Hodges G, Worley S
Antimicrob Agents Chemother. 1982; 22(5):909-11.
PMID: 6217786
PMC: 185683.
DOI: 10.1128/AAC.22.5.909.
Pharmacokinetic comparison of 5 g of azlocillin every 8 h and 4 g every 6 h in healthy volunteers.
Lander R, HENDERSON R, Pyszczynski D
Antimicrob Agents Chemother. 1989; 33(5):710-3.
PMID: 2751284
PMC: 172519.
DOI: 10.1128/AAC.33.5.710.
Pharmacokinetics of Bay k 4999, a new broad-spectrum penicillin.
Wise R, Cadge B, Gillett A, Bhamjee A, Livingston R, Welling P
Antimicrob Agents Chemother. 1979; 15(5):670-3.
PMID: 525984
PMC: 352736.
DOI: 10.1128/AAC.15.5.670.